Detail akcie DaVita online

Business Summary: DaVita Inc. is a healthcare provider focused on transforming care delivery to improve the quality of life for patients globally. The Company is a provider of kidney care services in the United States. Its United States dialysis and related lab services (U.S. dialysis) business treats patients with chronic kidney failure, end-stage kidney disease (ESKD). The Company’s robust platform delivers kidney care services and also includes established nephrology and payor relationships. The Company’s international operations provide dialysis and administrative services to a total of outpatient dialysis centers. The Company’s U.S. integrated kidney care (IKC) business provides integrated care and disease management services to patients in risk-based integrated care arrangements and to additional patients in other integrated care arrangements across the United States. It also maintains a few other ancillary services and investments outside its U.S. dialysis, U.S. IKC, or international operations.
Financial Summary: BRIEF: For the fiscal year ended 31 December 2023, Davita Inc revenues increased 5% to $12.14B. Net income before extraordinary items increased 26% to $691.5M. Revenues reflect U.S. dialysis segment increase of 3% to $10.85B, Other—Ancillary services segment increase of 18% to $1.29B. Net income benefited from U.S. dialysis segment income increase of 13% to $1.77B, Other—Ancillary services segment loss decrease of 91% to $8.7M.